Clinical Trials Browser

Urothelial Cancer

Erythroplasia, Hyperplasia, Leukoplakia, Oral, Mouth Neoplasms

Polycystic Ovary Syndrome

Carcinoma, Non-Small-Cell Lung

Posterior Fossa Ependymal Tumor

Rectal Neoplasms

Prostate Cancer Recurrent

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms, Pleural Effusion, Malignant

Advanced Solid Malignancies

Breast Neoplasms

TP53 Y220C Mutation

Breast Neoplasms

Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Prostatic Neoplasms

Polycystic Ovary Syndrome

Infertility, Metabolic Diseases, Polycystic Ovary Syndrome

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

Infertility, Female, Polycystic Ovary Syndrome

Leukoplakia, Oral

Pancreatic Adenocarcinoma

Polycystic Ovary Syndrome

Insulin Resistance, Polycystic Ovary Syndrome, Weight Loss, Metabolic Syndrome

Medulloblastoma, Cognitive Dysfunction

Anatomic Stage I Breast Cancer AJCC v8

Endometrial Hyperplasia, Endometrial Neoplasms

Clinical Trials

An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

SGLT2 Inhibitors in Treating Patients With PCOS

METLUNG

PNOC041

METCAP

COAST

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Morpheus-panBC

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer

Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

SHK002

PCOS

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

PCOS

Evaluation of the Chemo-preventive Effect of Combined Topical and Systemic Metformin on Oral Leukoplakia

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity

PCOS-COMBO (9)

Met Med Can

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer